85 related articles for article (PubMed ID: 12875804)
1. Effects of misattribution in assigning cause of death on prostate cancer mortality rates.
Hoffman RM; Stone SN; Hunt WC; Key CR; Gilliland FD
Ann Epidemiol; 2003 Jul; 13(6):450-4. PubMed ID: 12875804
[TBL] [Abstract][Full Text] [Related]
2. High Norwegian prostate cancer mortality: evidence of over-reporting.
Löffeler S; Halland A; Weedon-Fekjær H; Nikitenko A; Ellingsen CL; Haug ES
Scand J Urol; 2018 Apr; 52(2):122-128. PubMed ID: 29325479
[TBL] [Abstract][Full Text] [Related]
3. Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee.
Turner EL; Metcalfe C; Donovan JL; Noble S; Sterne JA; Lane JA; I Walsh E; Hill EM; Down L; Ben-Shlomo Y; Oliver SE; Evans S; Brindle P; Williams NJ; Hughes LJ; Davies CF; Ng SY; Neal DE; Hamdy FC; Albertsen P; Reid CM; Oxley J; McFarlane J; Robinson MC; Adolfsson J; Zietman A; Baum M; Koupparis A; Martin RM
Br J Cancer; 2016 Jun; 115(1):90-4. PubMed ID: 27253172
[TBL] [Abstract][Full Text] [Related]
4. A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995.
Albertsen PC; Walters S; Hanley JA
J Urol; 2000 Feb; 163(2):519-23. PubMed ID: 10647669
[TBL] [Abstract][Full Text] [Related]
5. Evidence of overestimating prostate cancer mortality in Estonia: a population-based study.
Innos K; Paapsi K; Alas I; Baum P; Kivi M; Kovtun M; Okas R; Pokker H; Rajevskaja O; Rautio A; Saretok M; Valk E; Žarkovski M; Denissov G; Lang K
Scand J Urol; 2022; 56(5-6):359-364. PubMed ID: 36073064
[TBL] [Abstract][Full Text] [Related]
6. Reliability of death certificates in prostate cancer patients.
Fall K; Strömberg F; Rosell J; Andrèn O; Varenhorst E;
Scand J Urol Nephrol; 2008; 42(4):352-7. PubMed ID: 18609293
[TBL] [Abstract][Full Text] [Related]
7. High prostate cancer mortality in Norway evaluated by automated classification of medical entities.
Hernes E; Johansson LA; Fosså SD; Pedersen AG; Glattre E
Eur J Cancer Prev; 2008 Aug; 17(4):331-5. PubMed ID: 18562957
[TBL] [Abstract][Full Text] [Related]
8. Assessment of causes of death in a prostate cancer screening trial.
Mäkinen T; Karhunen P; Aro J; Lahtela J; Määttänen L; Auvinen A
Int J Cancer; 2008 Jan; 122(2):413-7. PubMed ID: 17935123
[TBL] [Abstract][Full Text] [Related]
9. Trends in prostate cancer incidence and mortality in New Mexico are consistent with an increase in effective screening.
Gilliland F; Becker TM; Smith A; Key CR; Samet JM
Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):105-11. PubMed ID: 8049631
[TBL] [Abstract][Full Text] [Related]
10. Causes of death in men with prostate cancer: Results from the Danish Prostate Cancer Registry (DAPROCAdata).
Nguyen-Nielsen M; Møller H; Tjønneland A; Borre M
Cancer Epidemiol; 2019 Apr; 59():249-257. PubMed ID: 30861444
[TBL] [Abstract][Full Text] [Related]
11. High prostate cancer mortality in Norway: influence of Cancer Registry information?
Hernes E; Harvei S; Glattre E; Gjertsen F; Fosså SD
APMIS; 2005; 113(7-8):542-9. PubMed ID: 16086825
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of mortality data for interstitial lung diseases in New Mexico, USA.
Coultas DB; Hughes MP
Thorax; 1996 Jul; 51(7):717-20. PubMed ID: 8882079
[TBL] [Abstract][Full Text] [Related]
13. High accuracy of Swedish death certificates in men participating in screening for prostate cancer: a comparative study of official death certificates with a cause of death committee using a standardized algorithm.
Godtman R; Holmberg E; Stranne J; Hugosson J
Scand J Urol Nephrol; 2011 Sep; 45(4):226-32. PubMed ID: 21463227
[TBL] [Abstract][Full Text] [Related]
14. Ascertaining cause of death among men in the prostate cancer intervention versus observation trial.
Barry MJ; Andriole GL; Culkin DJ; Fox SH; Jones KM; Carlyle MH; Wilt TJ
Clin Trials; 2013; 10(6):907-14. PubMed ID: 23988464
[TBL] [Abstract][Full Text] [Related]
15. Mortality trends for benign prostatic hyperplasia and prostate cancer in English populations 1979-2006.
Duncan ME; Goldacre MJ
BJU Int; 2011 Jan; 107(1):40-5. PubMed ID: 20590542
[TBL] [Abstract][Full Text] [Related]
16. Use of statins and the risk of death in patients with prostate cancer.
Yu O; Eberg M; Benayoun S; Aprikian A; Batist G; Suissa S; Azoulay L
J Clin Oncol; 2014 Jan; 32(1):5-11. PubMed ID: 24190110
[TBL] [Abstract][Full Text] [Related]
17. 5α-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men With Prostate Cancer.
Azoulay L; Eberg M; Benayoun S; Pollak M
JAMA Oncol; 2015 Jun; 1(3):314-20. PubMed ID: 26181177
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer in American Indians, New Mexico, 1969 to 1994.
Gilliland FD; Key CR
J Urol; 1998 Mar; 159(3):893-7; discussion 897-8. PubMed ID: 9474177
[TBL] [Abstract][Full Text] [Related]
19. Cancer Specific Mortality in Men Diagnosed with Prostate Cancer before Age 50 Years: A Nationwide Population Based Study.
Thorstenson A; Garmo H; Adolfsson J; Bratt O
J Urol; 2017 Jan; 197(1):61-66. PubMed ID: 27328367
[TBL] [Abstract][Full Text] [Related]
20. The validity of death certificates: routine validation of death certification and its effects on mortality statistics.
Lahti RA; Penttilä A
Forensic Sci Int; 2001 Jan; 115(1-2):15-32. PubMed ID: 11056267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
